Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Granulocyte Colony-Stimulating Factor × Genitourinary × Clear all

Phase

Phase 2 7 Phase 1 6 Phase 3 4 Phase NA 1 Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 12 Lymphoid 10 Breast 2 Plasma cell 1 Other solid neoplasm 1 Myeloid 1 Genitourinary 1 Gastrointestinal 1 Classical hematology 1 CNS 1

Conditions

Prostatic Neoplasms 1

Interventions

Zoledronic Acid 15 enzalutamide 10 Leuprolide 9 Goserelin 8 bicalutamide 7 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 6 Triptorelin Pamoate 6 Prednisone 6 Nivolumab 6 Abiraterone Acetate 6 luprolide acetate gel depot 5 Sunitinib 5 Magnetic Resonance Spectroscopy 5 Everolimus 5 Dutasteride 5 Sodium Chloride 4 Propofol 4 Prednisolone 4 Androgen Antagonists 4 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 4 pazopanib 3 darolutamide 3 cabazitaxel 3 Trimethoprim, Sulfamethoxazole Drug Combination 3 Specimen Handling 3 Rocuronium 3 Mitomycin 3 Midazolam 3 Flutamide 3 Fentanyl 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01649635 2016-07-06

PROSPECTA

Sanofi

Phase 4 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡